| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Andrea Amerio, Chiara Stival, Cristina Bosetti, Giulia Carreras, Tiziana Fanucchi, Giuseppe Gorini, Alessandra Lugo, Roberta Pacifici, Gianluca Serafini, Anna Odone, Silvano Gallu. Cannabis use in repeated representative cross-sectional studies on Italian adults after the COVID-19 pandemic. Journal of psychiatric research. vol 164. 2023-07-07. PMID:37418885. |
in 2022, cannabis use was also more frequently reported in current smokers (or = 3.52), current e-cigarette and heated tobacco product users (or = 6.09 and 2.94, respectively), individuals with a risky alcohol consumption (or = 4.60), gamblers (or = 3.76), those with anxiety and depression (or = 2.50 and 2.80, respectively), those using psychotropic drugs (or = 8.96), those with a low quality of life (or = 1.91), and those sleeping less (or = 1.42). |
2023-07-07 |
2023-08-14 |
Not clear |
| Ryan J Watson, Antonia E Caba, Eric K Layland, Kay Simon, Ethan Morgan, E Jennifer Edelman, Philip A Chan, Lisa Eato. Co-occurring mental health and drug use experiences among Black and Hispanic/Latino sexual and gender diverse individuals. Journal of behavioral medicine. 2023-07-05. PMID:37407904. |
in a longitudinal, 5-wave sample of 300 black and hispanic/latino sexual and gender diverse (sgd) individuals collected between march 2020 and march 2022, we found a within-person association between greater than average levels of psychological distress (depression and anxiety) and more frequent extra-medical use of cannabis, inhalants, methamphetamines, and opioids over the span of two years. |
2023-07-05 |
2023-08-14 |
Not clear |
| Cecilia A Hinojosa, Amanda Liew, Xinming An, Jennifer S Stevens, Archana Basu, Sanne J H van Rooij, Stacey L House, Francesca L Beaudoin, Donglin Zeng, Thomas C Neylan, Gari D Clifford, Tanja Jovanovic, Sarah D Linnstaedt, Laura T Germine, Scott L Rauch, John P Haran, Alan B Storrow, Christopher Lewandowski, Paul I Musey, Phyllis L Hendry, Sophia Sheikh, Christopher W Jones, Brittany E Punches, Michael C Kurz, Robert A Swor, Lauren A Hudak, Jose L Pascual, Mark J Seamon, Elizabeth M Datner, Anna M Chang, Claire Pearson, David A Peak, Roland C Merchant, Robert M Domeier, Niels K Rathlev, Paulina Sergot, Leon D Sanchez, Steven E Bruce, Mark W Miller, Robert H Pietrzak, Jutta Joormann, Diego A Pizzagalli, John F Sheridan, Steven E Harte, James M Elliott, Ronald C Kessler, Karestan C Koenen, Samuel A McLean, Kerry J Ressler, Negar Fan. Associations of alcohol and cannabis use with change in posttraumatic stress disorder and depression symptoms over time in recently trauma-exposed individuals. Psychological medicine. 2023-06-13. PMID:37309917. |
associations of alcohol and cannabis use with change in posttraumatic stress disorder and depression symptoms over time in recently trauma-exposed individuals. |
2023-06-13 |
2023-08-14 |
Not clear |
| Cecilia A Hinojosa, Amanda Liew, Xinming An, Jennifer S Stevens, Archana Basu, Sanne J H van Rooij, Stacey L House, Francesca L Beaudoin, Donglin Zeng, Thomas C Neylan, Gari D Clifford, Tanja Jovanovic, Sarah D Linnstaedt, Laura T Germine, Scott L Rauch, John P Haran, Alan B Storrow, Christopher Lewandowski, Paul I Musey, Phyllis L Hendry, Sophia Sheikh, Christopher W Jones, Brittany E Punches, Michael C Kurz, Robert A Swor, Lauren A Hudak, Jose L Pascual, Mark J Seamon, Elizabeth M Datner, Anna M Chang, Claire Pearson, David A Peak, Roland C Merchant, Robert M Domeier, Niels K Rathlev, Paulina Sergot, Leon D Sanchez, Steven E Bruce, Mark W Miller, Robert H Pietrzak, Jutta Joormann, Diego A Pizzagalli, John F Sheridan, Steven E Harte, James M Elliott, Ronald C Kessler, Karestan C Koenen, Samuel A McLean, Kerry J Ressler, Negar Fan. Associations of alcohol and cannabis use with change in posttraumatic stress disorder and depression symptoms over time in recently trauma-exposed individuals. Psychological medicine. 2023-06-13. PMID:37309917. |
our study assessed the relationship between alcohol and cannabis use trajectories and ptsd and depression symptoms across 3 months in recently trauma-exposed civilians. |
2023-06-13 |
2023-08-14 |
Not clear |
| Jakob H Weiss, Brenden Tervo-Clemmens, Kevin W Potter, A Eden Evins, Jodi M Gilma. The Cannabis Effects Expectancy Questionnaire-Medical (CEEQ-M): Preliminary psychometric properties and longitudinal validation within a clinical trial. Psychological assessment. 2023-06-08. PMID:37289502. |
the questionnaire was developed for a randomized clinical trial of the effect of state cannabis registration (scr) card ownership on symptoms of pain, insomnia, anxiety, and depression in adults ( |
2023-06-08 |
2023-08-14 |
Not clear |
| Renée Martin-Willett, Carillon J Skrzynski, Hollis C Karoly, Joshua S Elmore, L Cinnamon Bidwel. Baseline affective symptomatology moderates acute subjective effects of high potency THC and CBD cannabis concentrates. Experimental and clinical psychopharmacology. 2023-06-08. PMID:37289543. |
we explored how baseline affective symptoms (anxiety and depression) relate to acute (i.e., immediate or short-term) subjective mood and intoxication effects during naturalistic use of cannabis concentrates. |
2023-06-08 |
2023-08-14 |
Not clear |
| Oskar Hougaard Jefsen, Annette Erlangsen, Merete Nordentoft, Carsten Hjorthø. Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder. JAMA psychiatry. 2023-05-24. PMID:37223912. |
cannabis use disorder and subsequent risk of psychotic and nonpsychotic unipolar depression and bipolar disorder. |
2023-05-24 |
2023-08-14 |
Not clear |
| Qian Liya Leng, Jamie O Lo, Shauna Rakshe, Andrea D Hildebrand, Olivia J Doyle, Kristen Mackiewicz Seghete, Alice Graha. The association between preconception cannabis use and depression and anxiety during pregnancy. General hospital psychiatry. vol 83. 2023-05-17. PMID:37196406. |
the association between preconception cannabis use and depression and anxiety during pregnancy. |
2023-05-17 |
2023-08-14 |
Not clear |
| Qian Liya Leng, Jamie O Lo, Shauna Rakshe, Andrea D Hildebrand, Olivia J Doyle, Kristen Mackiewicz Seghete, Alice Graha. The association between preconception cannabis use and depression and anxiety during pregnancy. General hospital psychiatry. vol 83. 2023-05-17. PMID:37196406. |
our study provides data on preconception cannabis use and cannabis use disorder (cud) during the pandemic and models the association between preconception cannabis use and depression and anxiety during pregnancy. |
2023-05-17 |
2023-08-14 |
Not clear |
| Brooke J Arterberry, Michael J Parks, Megan E Patric. The moderating role of mental health on the association between COVID-related stress, isolation, and economic hardship and using substances to cope. Preventive medicine reports. vol 34. 2023-05-16. PMID:37193220. |
similarly, covid-related economic hardships were associated with using marijuana to cope among those with more symptoms of depression. |
2023-05-16 |
2023-08-14 |
Not clear |
| Jessie B Lydiard, Herry Patel, Yoni Strugatsky, Wesley K Thompson, William E Pelham, Sandra A Brow. Prospective associations between cannabis use and depressive symptoms across adolescence and early adulthood. Psychiatry research. vol 325. 2023-05-05. PMID:37146464. |
cannabis use and occurrences of depression during adolescence are common. |
2023-05-05 |
2023-08-14 |
human |
| Jessie B Lydiard, Herry Patel, Yoni Strugatsky, Wesley K Thompson, William E Pelham, Sandra A Brow. Prospective associations between cannabis use and depressive symptoms across adolescence and early adulthood. Psychiatry research. vol 325. 2023-05-05. PMID:37146464. |
does depression lead to cannabis use, or does cannabis use lead to depression, or is it a combination of both? |
2023-05-05 |
2023-08-14 |
human |
| Jessie B Lydiard, Herry Patel, Yoni Strugatsky, Wesley K Thompson, William E Pelham, Sandra A Brow. Prospective associations between cannabis use and depressive symptoms across adolescence and early adulthood. Psychiatry research. vol 325. 2023-05-05. PMID:37146464. |
this study aimed to examine the temporal directionality of cannabis use and depression among a prospective, longitudinal, sequential cohort of 15 to 24-year-olds. |
2023-05-05 |
2023-08-14 |
human |
| Jessie B Lydiard, Herry Patel, Yoni Strugatsky, Wesley K Thompson, William E Pelham, Sandra A Brow. Prospective associations between cannabis use and depressive symptoms across adolescence and early adulthood. Psychiatry research. vol 325. 2023-05-05. PMID:37146464. |
multilevel regression models were run to assess concurrent (at the same time point) and prospective (1 year later) associations between cannabis use and depression. |
2023-05-05 |
2023-08-14 |
human |
| Jessie B Lydiard, Herry Patel, Yoni Strugatsky, Wesley K Thompson, William E Pelham, Sandra A Brow. Prospective associations between cannabis use and depressive symptoms across adolescence and early adulthood. Psychiatry research. vol 325. 2023-05-05. PMID:37146464. |
overall, the relationship between cannabis use and depression appears to be complex and not unidirectional. |
2023-05-05 |
2023-08-14 |
human |
| Kat Petrilli, Lindsey Hines, Sally Adams, Celia J Morgan, H Valerie Curran, Tom P Freema. High potency cannabis use, mental health symptoms and cannabis dependence: Triangulating the evidence. Addictive behaviors. vol 144. 2023-04-30. PMID:37121087. |
we hypothesised that users of high potency cannabis would have higher levels of (a) anxiety, (b) depression and (c) psychosis-like symptoms (d) cannabis dependence than users of lower potency cannabis. |
2023-04-30 |
2023-08-14 |
Not clear |
| H Clarke, M Fitzcharle. The evolving culture of medical cannabis in Canada for the management of chronic pain. Frontiers in pharmacology. vol 14. 2023-04-24. PMID:37089954. |
pain relief, sleep promotion and alleviation of distress, depression and anxiety are the most common reasons for cannabis use. |
2023-04-24 |
2023-08-14 |
Not clear |
| Daniel Ying-Heng Hua, Chandni Hindocha, Gianluca Baio, Rachel Lees, Natacha Shaban, Celia J Morgan, Ali Mofeez, H Valerie Curran, Tom P Freema. Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational psychiatry. vol 13. issue 1. 2023-04-21. PMID:37085531. |
one potential mechanism of cbd is increasing levels of anandamide, which has been implicated in psychiatric disorders including depression and cannabis use disorder. |
2023-04-21 |
2023-08-14 |
human |
| Daniel Ying-Heng Hua, Chandni Hindocha, Gianluca Baio, Rachel Lees, Natacha Shaban, Celia J Morgan, Ali Mofeez, H Valerie Curran, Tom P Freema. Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational psychiatry. vol 13. issue 1. 2023-04-21. PMID:37085531. |
we also investigated whether changes in plasma anandamide levels were associated with clinical outcomes relevant for cannabis use disorder (cannabis use, withdrawal, anxiety, depression). |
2023-04-21 |
2023-08-14 |
human |
| Simon Erridge, Sajed Mangoo, Mikael H Sodergre. Letter to the editor: reflections on the future of medical cannabis research for depression. Expert review of neurotherapeutics. 2023-04-20. PMID:37078172. |
letter to the editor: reflections on the future of medical cannabis research for depression. |
2023-04-20 |
2023-08-14 |
Not clear |